Understanding why some latina women discontinue participation in cancer prevention outreach

July 25, 2015, Roswell Park Cancer Institute

It has long been known that rates of breast and cervical cancer screening among Latinas are low compared to rates for U.S. women overall. A study led by researchers at Roswell Park Cancer Institute (RPCI) found that age and fear of cancer diagnosis are among the reasons why Latina women do not continue participation following breast and cervical cancer education programs. The research was published in the Journal of Health Communication: International Perspectives.

This research is a secondary analysis of a large randomized, controlled study reported earlier and was designed to specifically understand the characteristics of women who were lost to attrition for follow-up telephone calls following participation in the multisite, peer-led education program Esperanza y Vida (EyV).

Esperanza y Vida aims to address the low rates of breast and screening in the diverse Latina population and offers information and education in community settings delivered by lay health advisers and sobreviventes (). A narrative from the sobreviventes incorporates personal experiences to promote learning and increase self-efficacy for pap and mammography screenings.

In that earlier EyV intervention study, a participant was considered lost to follow-up if, for example, she did not provide a telephone number at registration, declined to complete the follow-up questions, or did not have a working telephone number. The secondary analysis only examined attrition at two months, as women lost to follow-up at this time were dropped from further analysis. Of the 908 Latina women who participated in the cancer education program and consented to follow-up, 76% were retained at the two-month follow-up assessment.

"Participant loss to follow-up represents a potentially important source of bias in research studies," says Deborah Erwin, PhD, Principal Investigator of the study and Director of the Office of Cancer Health Disparities Research at Roswell Park. "These findings are underscored by the fact that while there was a very high response rate for follow-up assessment two months after the program (77%)—especially for a group that includes many non-English-speaking, foreign-born women—unscreened women at that time could receive navigation assistance for screening, and the women lost to follow-up (23%) may remain unscreened without additional assistance."

Analysis of the data found that Latinas lost to attrition at the two-month follow-up assessment included women who were younger than 40 years of age (59.6%; most women in this group were ineligible for mammograms, but eligible for pap tests); those who felt that hearing a survivor's story would lead them to make an appointment for preventive screening (17.6%); and women who were afraid of hearing medical results (43.2%). More research would be required to determine whether the group of women impacted by a survivor's personal experiences went on to obtain screening on their own. The large share of women who were concerned about hearing medical results and who were no longer participating in the study demonstrates the continued need to address fears and emotional issues around screening.

"Knowing more about the reasons behind attrition characteristics provides insight for future studies," adds Dr. Erwin. "These findings contribute to the literature regarding the recruitment and retention of minorities, specifically Latinas and newer immigrants, in research studies, as well as to how attrition and the ability to follow up with Latina women of varying ages are understood."

Explore further: Can patient navigators reduce no-shows for cancer screening follow-up?

More information: Journal of Health Communication, Volume 20, Issue 7, 2015. DOI: 10.1080/10810730.2015.1018596

Related Stories

Can patient navigators reduce no-shows for cancer screening follow-up?

July 23, 2015
Researchers at Harvard Medical School and Brigham and Women's Hospital reported a 20% decline in the rate of missed appointments for cervical cancer evaluation following a Pap smear when a patient navigator program was initiated ...

What's the best test for cervical cancer? Pap, HPV or both?

June 9, 2014
Should U.S. women be screened for cervical cancer with Pap tests, HPV tests or both? According to researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) while the merits of screening ...

False breast cancer alarm has negative impact on health

May 27, 2015
The psychological strain of being told that you may have breast cancer may be severe, even if it turns out later to be a false alarm. This is the finding of new research from the University of Copenhagen, which has just been ...

Study finds decreased rates of high-grade cervical lesions in young women

June 22, 2015
A new analysis indicates that rates of high-grade cervical lesions decreased in young U.S. women after vaccines were made available to protect against human papillomavirus (HPV), but the trend may be due in part to changes ...

Millions given access to breast, cervical cancer screening: CDC

August 7, 2014
(HealthDay)—Millions of American women have benefited from a breast and cervical cancer screening program offered by the U.S. Centers for Disease Control and Prevention, according to a new report.

Interactive phone messages may promote cancer screening

March 27, 2014
(HealthDay)—Underserved Latina patients view interactive voice response (IVR) messages as an acceptable strategy to promote cancer screening, according to a study published online March 13 in the U.S. Centers for Disease ...

Recommended for you

'Druggable' cancer target found in pathway regulating organ size

November 20, 2018
It's known that cancer involves unchecked cell growth and that a biological pathway that regulates organ size, known at the Hippo pathway, is also involved in cancer. It's further known that a major player in this pathway, ...

Proposed cancer treatment may boost lung cancer stem cells, study warns

November 20, 2018
Epigenetic therapies—targeting enzymes that alter what genes are turned on or off in a cell—are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant. Researchers at Boston ...

Aspirin and omega-3 reduce pre-cancerous bowel polyps

November 19, 2018
Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.

New drug discovery could halt spread of brain cancer

November 19, 2018
The tissues in our bodies largely are made of fluid. It moves around cells and is essential to normal body function.

A molecule for fighting muscular paralysis

November 19, 2018
Myotubular myopathy is a severe genetic disease that leads to muscle paralysis from birth and results in death before two years of age. Although no treatment currently exists, researchers from the University of Geneva (UNIGE), ...

Scientists trained a computer to classify breast cancer tumors

November 19, 2018
Using technology similar to the type that powers facial and speech recognition on a smartphone, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have trained a computer to analyze breast ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.